The Patent Finder

Costim Pharmaceuticals Inc.

Also on record
Records under this name other than patents Costim Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Costim Pharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,683,048Antibody Molecules to PD-1 and Uses Thereof
conveyed to Novartis AG
In force
 · High confidence
In forceHigh confidence
US 9,815,898Antibody Molecules to PD-1 and Uses Thereof
conveyed to Novartis AG
In force
 · High confidence
In forceHigh confidence
US 9,605,070Antibody Molecules to TIM-3 and Uses Thereof
conveyed to Novartis AG
In force
 · High confidence
In forceHigh confidence
US 9,884,913Antibody Molecules to TIM-3 and Uses Thereof
conveyed to Novartis AG - now held by Novartis AG
In force
 · High confidence
In forceHigh confidence
US 10,472,419Antibody Molecules to TIM-3 and Uses Thereof
conveyed to Novartis AG - now held by Novartis AG
In force
 · High confidence
In forceHigh confidence
US 10,981,990Antibody Molecules to TIM-3 and Uses Thereof
conveyed to Novartis AG
In force
 · High confidence
In forceHigh confidence
US 11,155,620Method of Detecting TIM-3 Using Antibody Molecules to TIM-3
conveyed to Novartis AG
In force
 · High confidence
In forceHigh confidence
US 9,908,936Antibody Molecules to LAG-3 and Uses Thereof
conveyed to Novartis AG - now held by Immutep S.A.S.
In force
 · High confidence
In forceHigh confidence
US 12,252,535Antibody Molecules to LAG-3 and Uses Thereof
conveyed to Novartis AG - now held by Immutep S.A.S.
In force
 · High confidence
In forceHigh confidence
US 12,600,777Combination Therapies Comprising Antibody Molecules to LAG-3
conveyed to Novartis AG
In force
 · Low confidence
In forceLow confidence
10 of 28 records shown.
Pro members see all 28.
Pro members: see all 28 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited